Other Species / Isoforms
  RHOA (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T19-p
GDGACGKtCLLIVFs
0 2
RHOA (human) GDGACGKtCLLIVFs T19-p
RHOA (mouse) GDGACGKtCLLIVFs T19-p
RHOA (rat) GDGACGKTCLLIVFS T19
S26-p
tCLLIVFsKDQFPEV
1 2
RHOA (human) tCLLIVFsKDQFPEV S26-p
RHOA (mouse) tCLLIVFsKDQFPEV S26-p
RHOA (rat) TCLLIVFSKDQFPEV S26
Y34-p
KDQFPEVyVPTVFEN
Upstream
Downstream
1 15
Effects on Modified Protein
  • activity, inhibited
  • molecular association, regulation
Effects on Biological Processes:
  • cytoskeletal reorganization
  • signaling pathway regulation
Putative in vivo kinases:
  • BCR-ABL1 (human)
  • Src (human)
Treatment
  • imatinib
  • vanadate
RHOA (human) KDQFPEVyVPTVFEN Y34-p
RHOA (mouse) KDQFPEVYVPTVFEN Y34
RHOA (rat) KDQFPEVYVPTVFEN Y34
Y34-ad
KDQFPEVyVPTVFEN
1 0
RHOA (human) KDQFPEVyVPTVFEN Y34-ad
RHOA (mouse) KDQFPEVYVPTVFEN Y34
RHOA (rat) KDQFPEVYVPTVFEN Y34
Y42-p
VPTVFENyVADIEVD
Upstream
Downstream
4 0
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
  • protein degradation
  • ubiquitination
Effects on Biological Processes:
  • carcinogenesis, inhibited
  • cell growth, induced
  • cell motility, induced
  • signaling pathway regulation
  • transcription, induced
Kinase, in vitro:
  • Met (human)
Putative in vivo kinases:
  • Met (human)
Treatment
  • apocynin
  • DPI
  • H2O2
  • HGF
  • NAC
  • phorbol_ester
  • PP2
  • tivantinib
  • Wnt3a
RHOA (human) VPTVFENyVADIEVD Y42-p
RHOA (mouse) VPTVFENyVADIEVD Y42-p
RHOA (rat) VPTVFENYVADIEVD Y42
Y66-p
DTAGQEDyDRLRPLS
Upstream
Downstream
1 14
Effects on Modified Protein
  • activity, inhibited
  • molecular association, regulation
Effects on Biological Processes:
  • cytoskeletal reorganization
  • signaling pathway regulation
Putative in vivo kinases:
  • BCR-ABL1 (human)
  • Src (human)
Treatment
  • vanadate
RHOA (human) DTAGQEDyDRLRPLS Y66-p
RHOA (mouse) DTAGQEDYDRLRPLS Y66
RHOA (rat) DTAGQEDYDRLRPLS Y66
S88-p
LMCFSIDsPDSLENI
Upstream
Downstream
1 0
Effects on Modified Protein
  • activity, induced
  • intracellular localization
Effects on Biological Processes:
  • cytoskeletal reorganization
Kinase, in vitro:
  • ERK1 (human)
Putative in vivo kinases:
  • ERK1 (human)
Treatment
  • EGF
  • U0126
RHOA (human) LMCFSIDsPDSLENI S88-p
RHOA (mouse) LMCFSIDSPDSLENI S88
RHOA (rat) LMCFSIDSPDSLENI S88
T100-p
ENIPEKWtPEVkHFC
Upstream
Downstream
1 0
Effects on Modified Protein
  • activity, induced
  • intracellular localization
Effects on Biological Processes:
  • cytoskeletal reorganization
Kinase, in vitro:
  • ERK1 (human)
Putative in vivo kinases:
  • ERK1 (human)
Treatment
  • EGF
  • U0126
RHOA (human) ENIPEKWtPEVkHFC T100-p
RHOA (mouse) ENIPEKWTPEVkHFC T100
RHOA (rat) ENIPEKWTPEVKHFC T100
K104-ub
EKWtPEVkHFCPNVP
0 6
RHOA (human) EKWtPEVkHFCPNVP K104-ub
RHOA (mouse) EKWTPEVkHFCPNVP K104-ub
RHOA (rat) EKWTPEVKHFCPNVP K104
K118-ub
PIILVGNkkDLRNDE
0 6
RHOA (human) PIILVGNkkDLRNDE K118-ub
RHOA (mouse) PIILVGNkkDLRNDE K118-ub
RHOA (rat) PIILVGNKKDLRNDE K118
K119-ub
IILVGNkkDLRNDEH
0 3
RHOA (human) IILVGNkkDLRNDEH K119-ub
RHOA (mouse) IILVGNkkDLRNDEH K119-ub
RHOA (rat) IILVGNKKDLRNDEH K119
T127-p
DLRNDEHtrRELAkM
0 3
RHOA (human) DLRNDEHtrRELAkM T127-p
RHOA (mouse) DLRNDEHTRRELAKM T127
RHOA (rat) DLRNDEHTRRELAkM T127
R128-m1
LRNDEHtrRELAkMk
0 1
RHOA (human) LRNDEHtrRELAkMk R128-m1
RHOA (mouse) LRNDEHTRRELAKMk R128
RHOA (rat) LRNDEHTRRELAkMk R128
K133-ub
HtrRELAkMkQEPVk
0 2
RHOA (human) HtrRELAkMkQEPVk K133-ub
RHOA (mouse) HTRRELAKMkQEPVK K133
RHOA (rat) HTRRELAKMkQEPVK K133
K133
HtrRELAKMkQEPVk
0 1
RHOA (human) HtrRELAKMkQEPVk K133
RHOA (mouse) HTRRELAKMkQEPVK K133
RHOA (rat) HTRRELAkMkQEPVK K133-ac
K135-ub
rRELAkMkQEPVkPE
Upstream
Downstream
1 107
Effects on Modified Protein
  • protein degradation
Regulatory protein:
  • FBXL19 (human)
RHOA (human) rRELAkMkQEPVkPE K135-ub
RHOA (mouse) RRELAKMkQEPVKPE K135-ub
RHOA (rat) RRELAkMkQEPVKPE K135-ub
K135
rRELAkMKQEPVkPE
0 1
RHOA (human) rRELAkMKQEPVkPE K135
RHOA (mouse) RRELAKMKQEPVKPE K135
RHOA (rat) RRELAkMkQEPVKPE K135-ac
K140-ub
kMkQEPVkPEEGRDM
0 2
RHOA (human) kMkQEPVkPEEGRDM K140-ub
RHOA (mouse) KMkQEPVKPEEGRDM K140
RHOA (rat) kMkQEPVKPEEGRDM K140
Y156-p
NRIGAFGyMECsAKT
0 29
RHOA (human) NRIGAFGyMECsAKT Y156-p
RHOA (mouse) NRIGAFGyMECSAkT Y156-p
RHOA (rat) NRIGAFGyMECSAKT Y156-p
S160-p
AFGyMECsAKTkDGV
0 1
RHOA (human) AFGyMECsAKTkDGV S160-p
RHOA (mouse) AFGyMECSAkTKDGV S160
RHOA (rat) AFGyMECSAKTKDGV S160
K162
GyMECsAKTkDGVRE
0 1
RHOA (human) GyMECsAKTkDGVRE K162
RHOA (mouse) GyMECSAkTKDGVRE K162-ub
RHOA (rat) GyMECSAKTKDGVRE K162
K164-ub
MECsAKTkDGVREVF
0 1
RHOA (human) MECsAKTkDGVREVF K164-ub
RHOA (mouse) MECSAkTKDGVREVF K164
RHOA (rat) MECSAKTKDGVREVF K164
S188-p
ARRGKKKsGCLVL__
Upstream
Downstream
15 0
Effects on Modified Protein
  • activity, inhibited
  • enzymatic activity, inhibited
  • intracellular localization
  • molecular association, regulation
  • phosphorylation
  • protein stabilization
Effects on Biological Processes:
  • apoptosis, inhibited
  • cell differentiation, induced
  • cell motility, induced
  • cytoskeletal reorganization
  • endocytosis, inhibited
Kinase, in vitro:
  • PKACA (human)
  • PKACA (mouse)
  • PKG1 (human)
Putative in vivo kinases:
  • PKACA (human)
  • PKACA (mouse)
Regulatory protein:
  • CTH (human)
  • MST1 (human)
Treatment
  • 8-Rp-cAMP
  • bisindolylmaleimide
  • BX795
  • cAMP_analog
  • coculture
  • colforsin
  • GSK2334470
  • H-89
  • IC87114
  • insulin
  • KT5720
  • LY2090314
  • rapamycin
  • salbutamol
  • SNP
  • sodium_hydrosulfide
  • U0126
RHOA (human) ARRGKKKsGCLVL__ S188-p
RHOA (mouse) ARRGKKKsGCLIL__ S188-p
RHOA (rat) ARRGKKKSGCLIL__ S188